Dissertations / Theses on the topic 'Tumours'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 dissertations / theses for your research on the topic 'Tumours.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Kamel, H. M. N. "Ultrastructural aspects of tumours and anti-tumour therapy." Thesis, University of Glasgow, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.375440.
Full textKhan, M. S. "Circulating tumour cells and biomarkers in neuroendocrine tumours." Thesis, University College London (University of London), 2013. http://discovery.ucl.ac.uk/1380186/.
Full textde, Foy K. "Analysis of candidate tumour suppressor genes in sporadic ovarian tumours." Thesis, University of Cambridge, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.598448.
Full textOrme, Michelle Elaine. "The vascularization of solid tumours : mathematical models of tumour angiogenesis and vascular tumour growth." Thesis, University of Bath, 1996. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.362238.
Full textLiu, Lu. "Oncogenes and tumour suppressor genes in human central nervous system tumours /." Stockholm, 1999. http://diss.kib.ki.se/1999/91-628-3532-7/.
Full textGillmore, Roopinder. "Studies of the Wilms' tumour 1 gene in patients with solid tumours." Thesis, Imperial College London, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.432012.
Full textByrne, Niall Maurice. "Importance of the tumour microenvironment in the treatment response of prostate tumours." Thesis, Ulster University, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.674729.
Full textEuler, Henrik von. "Electrochemical treatment of tumours /." Uppsala : Dept. of Small Animal Clinical Sciences, Swedish Univ. of Agricultural Sciences ([Institutionen för kirurgi och medicin - smådjur], Sveriges lantbruksuniv.), 2002. http://epsilon.slu.se/v133.pdf.
Full textDwivedi, Anupma. "Bacteriolytic therapy of tumours." Thesis, University of Ulster, 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.589756.
Full textBurns, Alice Sin Ying Wai. "The role of the p53 tumour suppressor pathway in central primitive neuroectodermal tumours." Thesis, University of Newcastle Upon Tyne, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.300357.
Full textHarwood, Reuben. "The response of tumour-infiltrating myeloid cells to the chemotherapy-treatment of tumours." Thesis, University of Sheffield, 2013. http://etheses.whiterose.ac.uk/6640/.
Full textAricò, Arianna. "Interaction between tumour and microenvironment - molecular mechanisms of cell migration in canine tumours." Doctoral thesis, Università degli studi di Padova, 2013. http://hdl.handle.net/11577/3423396.
Full textNegli ultimi anni nell’ambito dell’oncologia, diversi studi hanno identificato diverse molecole target implicate nella cancerogenesi e sono stati evidenziati numerosi processi attraverso cui le cellule tumorali sono in grado di accumulare alterazioni genetiche. Recentemente, la progressione del tumore è stata riconosciuta come il prodotto di un complesso crosstalk tra le cellule tumorali e il tessuto circostante, chiamato stroma tumorale. Questo stroma è noto per influenzare la crescita del tumore ed è composto da diverse tipologie cellulari, che comprendono cellule endoteliali della circolazione sanguigna e linfatica, fibroblasti stromali ed una varietà di cellule derivate dal midollo osseo, come macrofagi, mastociti, neutrofili, linfociti e cellule staminali mesenchimali. Ulteriormente, il microambiente di supporto è generato e modulato da cellule tumorali attraverso la produzione e attivazione di fattori di crescita prodotti dallo stroma stesso, come Vascular Endothelial Growth Factor (VEGF), Platelet-Derived Growth Factor (PDGF) e Transforming Growth Factor-beta (TGF). Concomitante all’alterata espressione di questi fattori e per il loro effetto autocrino e paracrino sulle cellule tumorali e su quelle stromali, le cellule neoplastiche iniziano a produrre enzimi proteolitici, come metalloproteasi di matrice (Matrix metalloproteinases - MMPs). Le MMPs operano il rimodellamento della matrice extra cellulare e della membrana basale, attivando così fattori di crescita legati alla superficie cellulare e alla matrice stessa. Tutti questi processi contribuiscono all’esteso crosstalk tra il microambiente e le cellule tumorali. Il microambiente quindi è implicato nella regolazione della crescita cellulare, determinando neoangiogenesi, invasione, metastasi tumorali e influenzando il risultato della terapia. Anche se le cellule stromali non sono considerabili fenotipicamente maligne, il loro ruolo nel sostenere la crescita della neoplasia è essenziale per la sopravvivenza del tumore. Con questo presupposto, le cellule del microambiente sono diventate un bersaglio attrattivo per diversi agenti terapeutici. Il progetto di ricerca è stato suddiviso in diverse fasi per identificare i meccanismi molecolari implicati nella migrazione cellulare, nell'angiogenesi e nella crescita neoplastica, da parte di cellule stromali e dal loro crosstalk con le cellule tumorali, in diverse neoplasie del cane. Per lo studio sono state selezionate le tipologie tumorali più frequenti nel cane: tumore mammario, mastocitoma cutaneo, leucemie linfoidi e linfoma, analizzando i profili di espressione genica e proteica di diversi fattori di crescita (VEGF-TGF-beta-PDGF) e delle MMPs, in associazione al loro crosstalk e ad un loro eventuale ruolo prognostico. Sono stati ottenuti importanti risultati evidenziando lo scenario della progressione tumorale e il ruolo del microambiente in oncologia veterinaria. E’ stato dimostrato che: - MMP-2, MT1-MMP, MMP-9 sono significativamente coinvolte nel tumore mammario ed è stato descritto un loro ruolo rilevante del compartimento stromale; - MMP-9 e VEGF-A sono associati al grado istologico nei mastocitomi cutanei; - MMP-9, MT1-MMP, TIMP-1 e VEGF sono correlate nel linfoma T e nei cani con linfoma con stadio clinico più alto; - MT1-MMP e TIMP-2 hanno un ruolo nella patogenesi nelle leucemie linfoblastiche acute; - Nella leucemia linfocitica cronica, i leucociti residui normali mostrano un'influenza significativa nell'espressione di MMP-9, MT1-MMP, VEGF e dei TIMPs; - Il linfoma e la leucemia nel modello in vitro mostrano una considerevole discrepanza per alcune MMPs e VEGF che avvalora l'importanza del microambiente in vivo; - L’espressione genica del PDGF-B è significativa nei linfomi T e nei linfomi cutanei. E’ stato inoltre proposto un loop funzionale autocrino e/o paracrino di stimolazione della crescita della neoplasia, dovuto alla co-espressione dei PDGFs e dei recettori in diversi tempi durante la malattia. I risultati ottenuti potrebbero migliorare significativamente la comprensione della cancerogenesi nei tumori più frequenti nel cane. I dati qui sintetizzati mostrano un ruolo primario del microambiente durante la carcinogenesi. Lo sviluppo di nuove terapie antitumorali che colpiscano il processo di formazione di metastasi, la crescita e la differenziazione della neoplasia, interferendo con la capacità delle cellule tumorali di trasmigrare nel sangue e nei vasi linfatici e di invadere il tessuto connettivo, sarà ampiamente perseguito in oncologia veterinaria nel futuro prossimo. Sono però necessari ulteriori studi per indicare se l'uso di agenti chemio-preventivi per controllare la funzione ed il comportamento delle cellule nel microambiente possa essere un importante approccio al controllo complessivo del cancro.
Ferguson, Mary L. "Angiogenesis in human lung tumours." Thesis, University of Oxford, 2008. http://ora.ox.ac.uk/objects/uuid:865de25c-1ac3-4a30-85fa-a9fc677bfcc2.
Full textChow, Ling-yu Velda, and 周令宇. "Surgical management of pharyngoesophageal tumours." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2015. http://hdl.handle.net/10722/212561.
Full textpublished_or_final_version
Surgery
Master
Master of Surgery
Di, Nicolantonio Federica. "Multidrug resistance in solid tumours." Thesis, University College London (University of London), 2004. http://discovery.ucl.ac.uk/1354622/.
Full textBell, Daphne Winifred. "Molecular analysis of ovarian tumours." Thesis, Queen's University Belfast, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.317548.
Full textHamblin, T. J. "Immunological features of lymphoid tumours." Thesis, University of Southampton, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.378383.
Full textKostoula, V. "Therapeutic targets in neuroendocrine tumours." Thesis, University College London (University of London), 2010. http://discovery.ucl.ac.uk/133930/.
Full textSchofield, James W. "Aspects of modelling solid tumours." Thesis, University of Oxford, 2010. http://ora.ox.ac.uk/objects/uuid:b7c50880-ed03-451e-9841-209f2de6a982.
Full textLam, Alfred. "Molecular Pathology of Oesophageal Tumours." Thesis, Griffith University, 2006. http://hdl.handle.net/10072/365187.
Full textThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Medicine
Full Text
Bundell, Christine Stephanie. "Immune recognition and editing of tumours expressing multiple antigenic epitopes in two murine models." University of Western Australia. School of Medicine and Pharmacology, 2007. http://theses.library.uwa.edu.au/adt-WU2007.0067.
Full textSeng, Tzer Jing. "Identification of candidate tumour suppressor genes on chromosome 22 in central nervous system tumours." Thesis, University of Cambridge, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.615650.
Full textFeakins, Roger Mark. "The pathogenesis and progression of gastrointestinal stromal tumours and of fibroepithelial tumours of the breast are influenced by a variety of growth factors and tumour-related proteins." Thesis, Queen Mary, University of London, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.510912.
Full textCremin, Bryan J. "Imaging of tumours of the urinary tract in children, with particular reference to Wilms' tumour." Doctoral thesis, University of Cape Town, 1986. http://hdl.handle.net/11427/27214.
Full textZar, Niklas. "Epidemiological Studies of Small Intestinal Tumours." Doctoral thesis, Uppsala University, Department of Surgical Sciences, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8842.
Full textMalignant tumours of the small intestine are rare. Age-standardised incidence in Europe is between 0.5-1.5 per 100 000. As the small intestine represents more than 90 % of the gastrointestinal mucosal surface, it is surprising that it gives rise to less than 2 % of gastrointestinal malignancies. The dominating histological subtypes are carcinoids and adenocarcinomas.
We used three population-based registries in Sweden to study survival, second malignant tumours, causes of death, and Crohn’s disease as a risk factor for small intestinal adenocarcinoma and carcinoid.
We evaluated tumour site, sex, age, and year of diagnosis as prognostic factors. For adenocarcinomas there was no difference in survival between duodenal and jejunal/ileal tumours. Women with jejunal/ileal adenocarcinomas showed higher probabilities of survival than men, while no such relation was found for duodenal tumours. Old age correlated with poor survival for duodenal tumours, and prognosis has improved in later years. For carcinoids, duodenal tumours had a more favourable prognosis than jejunal/ileal tumours. There was no difference in survival between sexes. Old age correlated with poor survival, and survival has improved in recent years.
Female patients with adenocarcinoma had increased risk of acquiring cancer in the genital organs and breasts, and both sexes had increased risks of second tumours in the gastrointestinal tract and skin. Men with carcinoid tumours had increased risk of prostate cancer. Both sexes had increased risk of malignant melanoma and malignancies of endocrine organs.
Patients with adenocarcinoma had increased risk of dying from malignant diseases other than the primary small intestinal cancer and from gastrointestinal disease. The cohort with carcinoid had higher than expected risk of dying from malignant disease, gastrointestinal disease, and cardiovascular disease.
Patients with Crohn’s disease had increased risk of small intestinal adenocarcinoma and carcinoid, and the risk has increased for patients diagnosed in recent years.
Ridgway, Paul French. "Tumours : wounds that do not heal." Thesis, Imperial College London, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.404832.
Full textBlomqvist, Lennart. "Magnetic resonance imaging of rectal tumours /." Stockholm, 1997. http://diss.kib.ki.se/1997/91-628-2797-9.
Full textBolger, Brendan Stephen. "Cell cycle kinetics in cervical tumours." Thesis, Imperial College London, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.294984.
Full textAbdelrahman, Mostafa. "Characterising tumours using high-frequency ultrasound." Thesis, University of Leeds, 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.581448.
Full textChen, Chao. "In vivo AC electroporation for tumours." Thesis, University of York, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.516546.
Full textChan, R. "Molecular genetic analysis of oligodendroglial tumours." Thesis, University of Cambridge, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.597427.
Full textCheung, Pik-shan, and 張碧珊. "Molecular diagnosis of soft tissue tumours." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B42905370.
Full textFerry, B. L. "Cytotoxic effector cells in rat tumours." Thesis, University of Nottingham, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.355290.
Full textWard, Samantha Jane. "Genetic abnormalities in paediatric glial tumours." Thesis, University College London (University of London), 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.404885.
Full textKing, Catherine Anne. "Idiotypic vaccination against B cell tumours." Thesis, University of Southampton, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.241861.
Full textMirbahai, Leda. "DNA methylation profiling of fish tumours." Thesis, University of Birmingham, 2012. http://etheses.bham.ac.uk//id/eprint/3633/.
Full textKarpathakis, A. "Molecular profiling of gastrointestinal neuroendocrine tumours." Thesis, University College London (University of London), 2015. http://discovery.ucl.ac.uk/1461038/.
Full textMacLaurin, James Normand. "The buckling of capillaries in tumours." Thesis, University of Oxford, 2011. http://ora.ox.ac.uk/objects/uuid:ba252220-3c06-4d49-8696-655f6fefcd31.
Full textBlom, Erik. "Towards Hybrid Modeling of Avascular Tumours." Thesis, Uppsala universitet, Institutionen för informationsteknologi, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-448703.
Full textCheung, Pik-shan. "Molecular diagnosis of soft tissue tumours." Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B42905370.
Full textDavidson, Callam Titus. "11β-hydroxysteroid dehydrogenase type I inhibition in solid tumours." Thesis, University of Edinburgh, 2018. http://hdl.handle.net/1842/33047.
Full textTai, Kai-chun Dora, and 戴啟真. "Krukenberg tumours of colorectal origin: experience of a tertiary referral centre and review of theliterature." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2010. http://hub.hku.hk/bib/B4562043X.
Full textHentschke, Patrik. "Anti-tumour effect in solid tumours, tolerance and immune reconstitution after allogeneic haematopoietic stem cell transplantation /." Stockholm, 2004. http://diss.kib.ki.se/2004/91-7349-800-9/.
Full textNilsson, Eva. "Modelling of the electrochemial treatment of tumours." Doctoral thesis, KTH, Chemical Engineering and Technology, 2001. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-2933.
Full textThe electrochemical treatment (EChT) of tumours entails thattumour tissue is treated with a continuous direct currentthrough two or more electrodes placed in or near the tumour.Promising results have been reported from clinical trials inChina, where more than ten thousand patients have been treatedwith EChT during the past ten years. Before clinical trials canbe conducted outside of China, the underlying destructionmechanism behind EChT must be clarified and a reliabledose-planning strategy has to be developed. One approach inachieving this is through mathematical modelling.
Mathematical models, describing the physicochemical reactionand transport processes of species dissolved in tissuesurrounding platinum anodes and cathodes, during EChT, aredeveloped and visualised in this thesis. The consideredelectrochemical reactions are oxygen and chlorine evolution, atthe anode, and hydrogen evolution at the cathode. Concentrationprofiles of substances dissolved in tissue, and the potentialprofile within the tissue itself, are simulated as functions oftime. In addition to the modelling work, the thesis includes anexperimental EChT study on healthy mammary tissue in rats. Theresults from the experimental study enable an investigation ofthe validity of the mathematical models, as well as of theirapplicability for dose planning.
The studies presented in this thesis have given a strongindication of the destruction mechanism involved in EChT. It isshown by the modelling work, in combination with theexperiments, that the most probable cause of tissue destructionis acidification at the anode and alkalisation at the cathode.The pH profiles obtained from the theoretical models have showngood correlation with the experimentally measured destructionzones, assuming that a pH above and below certain values causetissue destruction. This implies that the models presented inthis thesis could be of use in predicting the tumourdestruction produced through EChT, and thereby provide a basisfor a systematic dose planning of clinical treatments.Moreover, the models can serve as valuable tools in optimisingthe operating conditions of EChT.
Modelling work of theanode processes has explained the roleof chlorine in the underlying destruction mechanism behindEChT. It is found that the reactions of chlorine with tissueplay important roles as generators of hydrogen ions. Thecontribution of these reactions to the acidification of tissue,surrounding the anode, is strongly dependent on the appliedcurrent density and increases with decreasing currentdensity.
Keywords:cancer, direct current, dose planning,electrochemical treatment (EChT), electrotherapy, mathematicalmodelling, tumour.
Veerle, Flama. "Immunohistochemical study of canine mammary gland tumours." Thesis, Uppsala University, Department of Genetics and Pathology, 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-6267.
Full textThis study was carried out to determine the phenotype of special dog mammary gland tumours that were grown in nude mice. 26 tumours were examined by the immunohistochemical ABC-Elite protocol. The tumour tissues were labelled with following anti-human antibodies:
- AE1/AE3 (pankeratin antibody) labelled epithelial and myoepithelial cells
- CD 31 labelled endothelial cells
- desmin labelled cross-striated and smooth muscle cells
- myosin labelled cross striated muscle cells
- neurofilament (NF) labelled nerve cells
- osteopontin labelled preosteoblasts, osteoblasts and osteocytes
- p63 labelled nuclei of the myoepithelial cells
- smooth muscle actin (SMA) labelled the cytoplasm of myoepithelial cells
- type I collagen labelled the extracellular matrix in connective tissue and bone
- type II collagen labelled the extracellular matrix in cartilage
- vimentin labelled fibroblasts, fibrocytes, lipocytes, smooth muscle cells, endothelial cells, nerve cells, macrophages and myoepithelial cells
The tumours were also submitted to a double immunolabelling study using p63 and SMA.
The study could not give a final conclusion about the origin the tumours. There was still need for more research to answer that question. However, the immunohistochemical technique was analysed in detail, in order to obtain perfect labelings.
Initially, all the antibodies were tested on normal dog tissue, to acquire the best working dilutions with the lowest background problems. In the tumours, good results were obtained with these dilutions for the antibodies p63, SMA, vimentin, desmin, NF, AE1/AE3 and CD 31. Except for type I collagen, type II collagen and osteopontin that gave too much unspecific labelling of the mouse connective tissue. Even, when using the Vector® M.O.M. blocking kit, the results were still very difficult to interpretate.
The antigen retrieval methods were evaluated for all the antibodies. The antibodies p63, SMA, vimentin, desmin, AE1/AE3, myosin, neurofilament and CD 31 needed the antigen retrieval treatment. The antibodies type I collagen and type II collagen needed the treatment with the enzyme pepsin, while osteopontin did not need any pretreatment at all.
The double immunolabelling with p63 and SMA gave excellent results. Different combinations were tried out with different substrates, namely Vector® Nova RED, Vector® DAB and Vector® SG. Vector® methyl green was used as counterstaining, but it interfered with the other substrates, and better results were obtained without this counterstaining.
Björklund, Peyman. "Wnt/β-Catenin Signalling in Parathyroid Tumours." Doctoral thesis, Uppsala University, Department of Surgical Sciences, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8317.
Full textPrimary hyperparathyroidism (pHPT) due to parathyroid tumours with hypersecretion of parathyroid hormone and hypercalcaemia is a common disease with incompletely understood etiology affecting more than 1 % of the population, primarily postmenopausal women. In secondary hyperparathyroidism (sHPT), parathyroid tumours develop in response to calcium and vitamin D deficiency generally in patients with uraemia. HPT is usually treated by surgical removal of enlarged parathyroid glands.
The aim of this thesis was to examine the Wnt/β-catenin signalling pathway in parathyroid tumours.
Aberrantly accumulated β-catenin was found in all analysed pHPT and sHPT tumours, with a stabilising homozygous mutation (Ser37Ala) in 7.3% of the pHPT tumours. Truncation of the APC protein was not found. MYC, a β-catenin target gene was overexpressed in a substantial fraction of pHPT and sHPT parathyroid tumours.
A parathyroid tumour cell line (sHPT-1) was established from a hyperplastic gland removed at operation of a patient with sHPT. The cells produced parathyroid hormone and grew with a doubling time of approximately 72 hours. Stabilised nonphosphorylated transcriptionally active β-catenin was expressed. Efficient transfection of siRNA against β-catenin decreased expression of cyclin D1 and MYC, and inhibited cell growth with ensuring cell death.
The Wnt coreceptor LRP5 was found expressed with an internal deletion of 142 amino acids (LRP5Δ) in 86% and 100% of pHPT and sHPT tumours, respectively. Stabilising mutation of β-catenin and expression of LRP5Δ was mutually exclusive. Expression of LRP5Δ was required to maintain the nonphosphorylated transcriptionally active ß-catenin level, MYC expression, parathyroid cell growth in vitro, and tumour growth in transplanted SCID mice. Wnt3 ligand and LRP5Δ strongly activated transcription, and LRP5Δ was insensitive to inhibition by DKK1.
Aberrant accumulation of β-catenin by stabilising mutation or expression of LRP5Δ appears as a common pathogenic pathway for hyperparathyroid disease. LRP5Δ in particular presents a potential target for therapeutic intervention.
Ghumman, Sukhmanjit. "Functional connectivity in patients with brain tumours." Mémoire, Université de Sherbrooke, 2018. http://hdl.handle.net/11143/12001.
Full textLe mode de fonctionement par défaut du cerveau est un réseau cérébral associé à la rêverie et à l’introspection. Des études récentes sur ce réseau ont découvert qu’il est perturbé dans plusieurs pathologies cérébrales. Par example, le mode de fonctionnement par défaut est modulé en démence, TDAH, dépression, schizophrénie et plusieurs autres maladies liés au cerveau. Ceci a mené à l’hypothèse que le mode de fonctionnement par défaut pourrait avoir un rôle dans la physiopathologie des maladies du système nerveux, ou pourrait être un marqueur utile du fonctionnement cérébral. Par contre, très peu d’études ont investigué l’effet de lésions chirurgicaux comme les tumeurs cérébrales sur le mode de fonctionnement par défaut. Par conséquent, le but de ce projet était de caractériser l’importance de l’histologie, de la localisation et de plusieurs autres paramètres de l’effet d’une tumeur cérébrale sur le mode de fonctionnement par défaut.
Kavanagh, Mary-Claire Anne. "Measurement of oxygen levels in murine tumours." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape10/PQDD_0009/NQ41447.pdf.
Full textMarits, Per. "On CD4+ T Lymphocytes in Solid Tumours." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8325.
Full textMohamed, Noor Dzul Azri. "DNA methylation in paediatric germ cell tumours." Thesis, University of Nottingham, 2013. http://eprints.nottingham.ac.uk/27671/.
Full text